PDS Biotechnology (FRA:EU6) FCF Yield %: -47.06 (As of Jun. 29, 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
37 GF Score
Price €0.76
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology FCF Yield %?

PDS Biotechnology FRA:EU6 -1.30% 37 FCF Yield % is -47.06 as of Jun. 29, 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 1,415 Biotechnology companies, PDS Biotechnology ranks worse than 82.33% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, PDS Biotechnology's Trailing 12-Month Free Cash Flow is €-19.88 Mil, and Market Cap is €43.19 Mil. Therefore, PDS Biotechnology's FCF Yield % for today is -47.06%.

The historical rank and industry rank for PDS Biotechnology's FCF Yield % or its related term are showing as below:

FRA:EU6' s FCF Yield % Range Over the Past 10 Years
Min: -47.06   Med: 0   Max: 0
Current: -47.06


FRA:EU6's FCF Yield % is ranked worse than
82.33% of 1415 companies
in the Biotechnology industry
Industry Median: -9.62 vs FRA:EU6: -47.06

PDS Biotechnology's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


PDS Biotechnology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


PDS Biotechnology FCF Yield % Related Terms


PDS Biotechnology FCF Yield % Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology FCF Yield % Chart

PDS Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.63 -6.73 -20.42 -54.24 -63.89

PDS Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.83 -57.02 -49.31 -34.09 -58.34

FRA:EU6 vs LTRN, AURX, VERU: FCF Yield % Comparison

For the Biotechnology subindustry, PDS Biotechnology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PDS Biotechnology FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's FCF Yield % falls into.


FRA:EU6
37GF Score
PDS Biotechnology Corp FRA:EU6
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

PDS Biotechnology's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-23.7 / 37.097528
=-63.89%

PDS Biotechnology's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.782 * 4 / 25.9321136
=-58.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -47.06 mean?
PDS Biotechnology (FRA:EU6) has a FCF Yield % of -47.06 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PDS Biotechnology and its competitors. According to the industry distribution chart, PDS Biotechnology ranks #1165 out of 1415 companies in the Biotechnology industry, placing it in the top 82.3%.
Is PDS Biotechnology's FCF Yield % too high?
PDS Biotechnology's current FCF Yield % is -47.06. Based on the distribution chart, PDS Biotechnology ranks #1165 out of 1415 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PDS Biotechnology has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's FCF Yield % compare to LTRN and AURX?
According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #1165 out of 1415 companies for FCF Yield %. This places PDS Biotechnology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current FCF Yield % is -47.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current FCF Yield % of -47.06. The current FCF Yield % is -47.06. PDS Biotechnology's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current FCF Yield % is -47.06 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
37GF Score

Get the complete analysis for FRA:EU6

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price